Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor
- 1 December 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 297 (6), C1490-C1500
- https://doi.org/10.1152/ajpcell.00049.2009
Abstract
Diabetic cardiomyopathy is characterized by interstitial fibrosis and cardiomyocyte hypertrophy and apoptosis. Also known as CCN2, connective tissue growth factor (CTGF) is implicated in the fibrosis; however, whether it contributes to cardiomyocytes changes and adverse effects of high glucose and lipids on these cells remains unknown. Hearts from streptozotocin-induced diabetic rats had elevated CTGF and changes of pathological myocardial hypertrophy, fibrosis, and cardiomyocyte apoptosis. Rat H9c2 cardiomyocytes were then treated with recombinant human (rh)CTGF, high glucose, or the saturated free fatty acid palmitate. Each reagent induced cell hypertrophy, as indicated by the ratio of total protein to cell number, cell size, and gene expression of cardiac hypertrophy marker genes atrial natriuretic peptide (ANP), and α-skeletal actin. Each treatment also caused apoptosis measured by increased caspase3/7 activity, apoptotic cells by transferase-mediated dUTP nick end labeling (TUNEL) assay, and lower viable cell number. Further studies showed CTGF mRNA was rapidly induced by high glucose and palmitate in H9c2 cells and in mouse neonatal cardiomyocyte primary cultures. small interfering RNA against CTGF blocked the high glucose and palmitate induction of hypertrophy and apoptosis. In addition, these CTGF effects were through the tyrosine kinase A (TrkA) receptor with tyrosine kinase activity, which has previously been implicated in CTGF signaling: TrkA was phosphorylated by CTGF, and a specific TrkA blocker abrogated CTGF-induced effects on hypertrophy and apoptosis. For the first time in any system, fatty acid is newly identified as a regulator of CTGF, and this work implicates autocrine CTGF as a mediator of adverse effects of high glucose and fatty acids in cardiomyocytes.This publication has 58 references indexed in Scilit:
- Connective tissue growth factor induces cardiac hypertrophy through Akt signalingBiochemical and Biophysical Research Communications, 2008
- Apoptosis in Patients with Dilated Cardiomyopathy and Diabetes: A Feature of Diabetic Cardiomyopathy?Hormone and Metabolic Research, 2007
- Diabetic Cardiomyopathy RevisitedCirculation, 2007
- Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responsesJournal of Cellular Physiology, 2007
- The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activatorJournal of Molecular and Cellular Cardiology, 2007
- Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivoProceedings of the National Academy of Sciences, 2006
- Disease-associated changes in the expression of ion channels, ion receptors, ion exchangers and Ca2+-handling proteins in heart hypertrophyToxicology and Applied Pharmacology, 2005
- Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cellsKidney International, 2005
- Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.JCI Insight, 1996
- Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitusHeart and Vessels, 1985